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CLINICAL INVESTIGATION
Depletion of glutathione from brain cells in hyponatremia
EDWARD C. CLARK, DARBBIE THOMAS, JANE BR, and RICHARD H. STERNS
University of Rochester School of Medicine, Rochester General Hospital, Department of Medicine, Division of Nephrology, Rochester, New York, USA
Depletion of glutathione from brain cells in hyponatremia. In response
to hyponatremia, brain cells extrude electrolytes and organic osmolytes,
thereby minimizing brain edema. We demonstrate that rat brain is
depleted of the antioxidant glutathione in response to hyponatremia and
that osmotically-induced loss of glutathione makes neuronal cells more
susceptible to oxidative injury. Total glutathione content of brain tissue
decreased from 6.80 0.14 jzmol/g dry wt in normonatremic controls to
5.00 0.31 jrmol/g dry wt after 72 hours of hyponatremia. Following slow
correction of hyponatremia, brain glutathione content returned to control
values (6.77 0.34 Lmol/g dry wt). Brain content of taurine, a 13-amino
acid with antioxidant properties, similarly decreased in hyponatremia
(29.6 0.9 to 17.1 1.2 rmoI/g dry wt), then increased with slow
correction (24.8 1.3 mol/g dry wt). Although taurine served as an
osmolyte in rat heart, liver and brain, osmotically-induced changes in
glutathione content were found only in brain. We also studied osmotically-
induced changes in glutathione and taurine content in C6 glioma and
SK-N-SH neuroblastoma cells. In both cell lines, adaptive decreases in
glutathione and taurine content were found in response to lowering
medium sodium concentration from 140 mM to 100 m. The cell content
of these solutes increased after returning to media containing 140 mrvi
sodium. Following exposure of both cell lines to hypoosmolar media, there
was no increase in media content of glutathione. This suggests that
osmotic depletion of glutathione is not due to cellular efflux of intact
glutathione. We questioned if osmotic depletion of glutathione and
taurine renders brain cells more susceptible to oxidative stress. Incubation
of SK-N-SH cells with 1.0 ms H202 for four hours induced greater
cytotytic injury in cells adapted to hypoosmolar media than in isoosmolar
controls. Hypoosmolar C6 glioma cells were not significantly more sensi-
tive to cytolytic injury from H202 than were cells grown in isosmolar
media. We conclude that hypoosmolality induces glutathione depletion in
rat brain in vivo and in cultured brain cells in vitro. Osmotic depletion of
this antioxidant renders SK-N-SH neuronal cells more susceptible to
oxidative injury.
In hyponatremia, reduction of brain solute content minimizes
osmotically-induced brain swelling. These solutes include electro-
lytes and organic osmolytes such as amino acids, polyols, and
trimethylamines [1, 21. Maintenance of constant water content in
the face of extracellular hypoosmolality assumes particular impor-
tance in brain given the rigid volume constraints imposed by the
surrounding calvarium. Loss of intracellular solutes in response to
reduced extracellular fluid osmolality has also been identified in
cultured brain cells in vitro [3].
Prominent among the organic osmolytes extruded from brain
cells in hyponatremia is the /3-amino acid, taurine 1j. In a variety
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of in vitro and in vivo models of oxidative injury, taurine, which is
normally present in brain at a concentration of approximately 5
mM [4], has been shown to serve as an antioxidant [5—91. Taurine
also ameliorates hypoxic brain injury [10—13]. The tripeptide
glutathione, the most abundant intracellular thiol in rat brain
(normally present at a concentration of approximately 2 mM) [14]
is well established as an important antioxidant. We demonstrate
that rat brain in vivo and cultured brain cells in vitro undergo
adaptive decreases in glutathione content in response to a reduc-
tion in extracellular fluid osmolality. We hypothesized that adap-
tive decreases in the cell content of the antioxidants taurine and
glutathione in response to extracellular hypoosmolality renders
brain cells more susceptible to superimposed oxidative injury.
This hypothesis was tested in cultured brain cells adapted to
hypoosmolar medium.
Methods
In vivo studies
Brain glutathione and taurine content were determined in three
groups of male Sprague-Dawley rats (300 to 350 g body wt):
normonatremic controls, chronic hyponatremia, and slowly cor-
rected chronic hyponatremia. Chronic hyponatremia was induced
by the subcutaneous infusion of desmopressin acetate (DDAVP,
Rhone-Poulenc Rorer, Malmo, Sweden) by mini-osmotic pump
(Alzet, Palo Alto, CA, USA) at a rate of 20 nglhr for 72 hours. All
animals were gavage fed a liquid low-electrolyte chow (ICN
Biomedicals, Cleveland, OH, USA) providing 9 ml H2O/100 g
body wt daily over the three-day induction period. Normonatre-
mic control animals were treated and fed identically to hyponatre-
mic rats except that mini-osmotic pumps contained only normal
saline. All animals were housed with a 12-hour light-dark cycle
and allowed free access to water overnight. Slow correction was
achieved by changing three-day hyponatremic rats from low-
electrolyte chow to regular chow for seven days and allowing the
mini-osmotic pumps to exhaust their desmopressin content. All
rats appeared well throughout the study period and survived until
sacrificed.
Normonatremic controls and chronic hyponatremia rats were
sacrificed for analysis at 72 hours and slowly corrected animals at
10 days. Animals were sacrificed by guillotine and their skulls
immediately bisected sagittally with an electric table saw. Both
hemispheres were promptly removed with one being placed in
liquid nitrogen for determination of glutathione and taurine
content, and the other hemisphere analyzed for water and elec-
trolyte content. No more than 15 seconds elapsed from the time of
sacrifice to the placement of brain tissue in liquid nitrogen. The
heart and liver were also rapidly removed and frozen. Frozen
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tissue was crushed under liquid nitrogen and total glutathione and
taurine were measured by reverse-phase HPLC following deny-
itization with phenylisothiocyanate (Pico-Tag, Waters, Milford,
MA, USA). Methionine sulfone was added to each tissue sample
as an internal standard. During derivitization, a significant frac-
tion of reduced glutathione (GSH) is oxidized to glutathione
disulfide (GSSG). Total glutathione was therefore calculated as
the sum of the GSH and GSSG peaks from each chromatogram.
Initial studies verified greater than 98% recovery of exogenous
GSH added to tissue samples. Total glutathione is expressed as
GSH equivalents.
Our technique of harvesting brain tissue was employed because
it allows the removal of both hemispheres intact and avoids the
need for anesthetic agents. Because there likely is some degree of
oxidation of GSH to GSSG during harvesting, we measured total
glutathione (GSH and GSSG). This approach has been employed
previously in studies of brain glutathione metabolism where brain
tissue was similarly harvested immediately after decapitation [15,
161. We did not measure brain lactate as part of our analysis.
Immediately upon removal, the remaining brain hemisphere
was weighed, placed in an oven at 100°C for 48 hours, and then
reweighed to determine its water content. Dried brain was then
crushed and extracted in 0.75 N HNO3 for 72 hours. Sodium and
potassium contents were determined by flame photometry (In-
strumentation Laboratories, Model 943, Lexington, MA, USA).
Brain water and solute data are expressed per gram of tissue dry
weight. Plasma sodium was determined by flame photometry on
trunk blood obtained at the time of sacrifice.
In vitro studies
C6 rat glioma cells and SK-N-SH human neurobiastoma cells
were obtained from American Type Culture Collection (Be-
thesda, MD, USA). C6 cells are a rat glial cell line which possess
several biochemical characteristics of oligodendroglia such as high
levels of 2'3' cyclic nucleotide, 3' phosphorylase and myelin
components [17, 18]. SK-N-SH cells are a human neuroblastoma
cell line with biochemical markers indicating neuronal origin, such
as the presence of dopamine f3-hydroxylase and both a-2 adren-
ergic and cholinergic receptors [19, 20]. The cells were grown to
confluence in Modified Eagle's Medium (MEM) supplemented
with 10% fetal bovine serum, 100 U/mi penicillin, and 100 j.rg/ml
streptomycin (MEM/FBS, Sigma Chemical Company, St. Louis,
MO, USA) in multiwell culture plates in a humidified incubator at
37°C with 5% CO2.
Once confluence was reached (3 days for C6 cells and 7 to 10
days for SK-N-SH cells), medium osmolality was lowered by
replacing existing media every 12 hours with media having a
sodium concentration that was 10 m lower. Thus, the medium
sodium concentration was lowered from 140 m to 100 m over
48 hours. Media with sodium concentrations of 140 mrvt, 130 mM,
120 mi, 110 m and 100 m were prepared to insure that their
substrate concentrations were identical. Stock MEM was diluted
with sterile water such that when 10% fetal calf serum was added,
a final sodium concentration of 100 m was achieved. NaCI was
then added to aliquots of this media to achieve media of graded
sodium concentrations. Potassium concentration in all media was
adjusted to 5 m. Based on preliminary studies, bicarbonate
concentration in all media was adjusted to 26 m in order to
maintain a measured pH of approximately 7.40 to 7.45 at the
termination of each study protocol. In wells where medium
osmolality was corrected back to normal, media was again
changed every 12 hours, increasing the sodium concentration in 10
m increments from 100 m to 140 m over 48 hours. Cell
viability was >98% in representative wells by Trypan blue exclu-
sion.
Total glutathione and taunine content in C6 and SK-N-SH cells
were determined under three conditions: isosmolar, hypoosmolar,
and hypoosmolar corrected to isosmolar. In this protocol, isosmo-
lar cells were maintained in a medium with a sodium concentra-
tion of 140 m for 96 hours, while in hypoosmolar cells sodium
concentration was lowered from 140 m to 100 m over 48 hours
and then kept at 100 m for an additional 48 hours. For corrected
hypoosmolality, the sodium concentration was lowered from 140
ifiM to 100 m over 48 hours and subsequently increased back to
140 m over an additional 48 hours. In all wells, media was
replaced every 12 hours with media of appropriate sodium
concentration.
At the termination of this protocol, media was aspirated from
each well and the cell monolayer washed twice with Hank's
buffered salt solution (HBSS) of appropriate osmolality. Cell
monolayers were then lysed with 0.1 N HCI, derivitized with
phenylisothiocyanate, and total glutathione and taurine concen-
trations were determined by HPLC. For each well, methionine
sulfone was added as an internal standard. Solute data are
expressed per milligram cell protein.
To explore the possibility of cellular efflux of glutathione as the
mechanism underlying its depletion by hypoosmolality, the fol-
lowing studies were performed. Both cell lines were grown to
confluence in six well-culture plates with isosmotic MEM/FBS.
MEM/FBS was then aspirated and each well washed three times
with isosmotic HBSS. A total of 1.5 ml MEM without FBS but
with sodium concentration adjusted to either 100 m or 140 mvi
was then added to culture wells. After a 60-minute incubation,
media were aspirated and solute content determined by HPLC as
described above. A 60-minute incubation period was chosen based
on the studies of Yudkoff and co-workers, who measured the
efflux of glutathione from cultured astrocytes [21]. Stock MEM
contains no glutathione or taurine. Because of the large media
volume relative to cellular volume, serum-free media was used in
these studies to ensure that any measured glutathione or taurine
in the media was due to cellular efflux. There was no detectable
glutathione or taurine in serum-free MEM before incubation with
brain cells when analyzed by our HPLC methodology. Quantities
of glutathione and taurine measured in the media after incubation
with brain cells were well within the sensitivity of our HPLC
analysis. Results are expressed as total nmoles in the media of
each well per milligram cell protein. Cell protein content was
measured by the Lowry method [22].
In separate studies, cultured brain cells adapted to hypoosmolar
medium were exposed to hydrogen peroxide to study their
susceptibility to oxidative stress. Because of the ability of a-keto
acids to efficiently scavenge H202 via non-enzymatic oxidative
decarboxylation [23], all culture media were pyruvate-free. SK-
N-SH cells were grown to confluence and medium sodium con-
centration lowered from 140 m to 100 m over 48 hours as
described above. In control cells, sodium concentration was
maintained at 140 mrvi. Cytolytic injury to cultured brain cells was
determined by 51Cr release as previously described [23]. To load
cells with 51Cr, media in each well was aspirated and replaced with
I ml of HBSS of appropriate osmolality containing 1 .tCi sodium
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Table 1. Plasma sodium, brain water and brain electrolyte content in
chronic hyponatremia
Control Hyponatremia Corrected hyponatremia
Plasma Na 143 1 108 3° 140 1
mM
Brain H20 3.84 0.02 4.01 0•03h 3.95 0.05
mug thy wt
Brain K 487 5 434 8° 515 4"
pEqig thy wt
Brain Na 228 2 196 4° 247 8
p.Eq/g thy wt
a P < 0.05 vs. control and corrected hyponatremia
"P < 0.05 vs. control, N = 9 for all groups
[51Cr]chromate (Amersham Corp., Arlington Heights, IL, USA).
Following a three-hour incubation with sodium [5'Cr] chromate,
cells were washed twice with HBSS, then media of appropriate
osmolality was replaced. After 51Cr loading, isosmolar and hy-
poosmolar SK-N-SH cells were incubated with 1.0 mM H202 for
four hours at 37°C with 5% CO2. Following this four hour
incubation, media was aspirated, combined with two washes with
HBSS of appropriate osmolality, and 51Cr activity counted. The
remaining cell monolayer was solubilized with 2 ml of 1.0 N
NaOH, aspirated, and combined with two 2-mi washes of the well
with water and counted separately. Percent 5Cr release was
calculated as "'Cr activity in the overlying medium divided by total
"'Cr activity. Cytolytic injury of isosmolar and hypoosmolar C6
glioma cells was similarly studied after a four hour incubation with
1.0 mM H202.
Statistical analysis
Data are presented as means standard error. In cell culture
studies, N refers to the number of replicate wells in each
experimental condition. The unpaired Student's I-test was utilized
to analyze differences between studies with two groups. In studies
of three or more groups, the unpaired Student's I-test with
Bonferroni's correction was employed. A P value <0.05 was
considered statistically significant.
Results
Tissue glutathione and taurine content in hyponatremia
Hyponatremia induced over three days caused the plasma
sodium to decrease from 143 1 mi in controls to 108 3 mM
in the hyponatremic group (Table 1). Following slow correction of
hyponatremia, plasma sodium increased to 140 1 m. Brain
water increased significantly from 3.84 0.02 mug dry wt in
controls to 4.01 0.03 mug thy wt in hyponatremia and returned
toward control values following the slow correction of hyponatre-
mia. Brain sodium and potassium contents decreased significantly
in hyponatremia and increased following its slow correction.
Brain total glutathionc content decreased significantly in re-
sponse to hyponatremia, falling from 6.80 0.14 to 5.00 0.31
irmol/g dry wt (Table 2). Brain taurine content similarly declined
from 29.6 0.9 imol/g dry wt in controls to 17.1 1.2 prnol/g dry
wt in the hyponatremic group. Both glutathione and taurine
returned to levels close to control following the correction of
hyponatremia. The concentration of total glutathione in brain
water can be calculated by dividing the brain glutathione content
(rmol/g dry wt) in each rat by its respective brain water content
Table 2. Tissue glutathione and taurine content in chronic hyponatremia
Corrected
Control Hyponatremia hyponatremia
Brain
Glutathione 6.80 0.14 5.00 0.31° 6.77 0.36
Taurine 29.6 0.9 17.1 1.2° 24.8 1.3°
N 9 9 9
Heart
.
Glutathione 4.96 0.46 5.01 0.29 5.01 0.34
Taurine 82.6 6.5 63.5 4.6" 80.8 5.4
N 9 9 9
Liver
Glutathione 24.77 2.44 26.37 1.78 21.97 2.16
Taurine 13.9 2.9 3.8 0.5° 10.4 1.1
N 9 8 8
Data are expressed as tmol/g dry wt.
a p < 0.01 vs. control and corrected
"p < 0.05 vs. control and corrected
P < 0.05 vs. control
(ml/g dry wt). In control, hyponatremic and corrected groups, this
yields values of 1.77 0.64 mrvi, 1.25 0.07 m, and 1.72 0.10
m, respectively. Corresponding values for brain taurine concen-
tration are 7.71 0.22 mM, 4.26 0.30 m, and 6.28 0.52 mM.
In heart tissue, taurine content decreased in response to
hyponatremia and returned to control values following its correc-
tion (Table 2). Total glutathione content, however, remained
constant in heart tissue in all three experimental conditions. A
similar pattern was identified in liver tissue with taurine content
decreasing in the hyponatremic group and returning toward
control values in slowly corrected rats. There was no statistical
difference in liver glutathione content between any of the three
groups. Thus, while taurine functioned as an organic osmolyte in
all three tissues studied, osmotic depletion of glutathione was
found only in brain. In Figure 1, individual data from all three
groups are pooled and tissue total glutathione and taurine con-
tents are plotted against plasma sodium. Brain total glutathione
correlates significantly with plasma sodium (r = 0.79, P < 0.01),
further indicating the osmotic responsiveness of glutathione in
brain; however, no such correlation was found for heart and liver.
Taurine content correlated significantly with plasma sodium in all
three tissues.
Glutathione and taurine content in cultured brain cells
In both C6 glioma and SK-N-SH neuroblastoma cells, hypoto-
nicity-induced depletion of both glutathione and taurine was
identified (Table 3). Following the reduction in medium sodium
concentration from 140 m to 100 mad, giutathione content in C6
cells fell from 6.33 1.94 to 4.26 1.04 nmol/mg protein. Taurine
content fell dramatically from 67.1 3.7 nmol/mg protein to
undetectable levels. Cell content of both glutathione and taurine
increased significantly from hypoosmolar values following the
return to an isotonic culture medium. In SK-N-SH cells, similar
findings were noted with glutathione and taurine contents de-
creasing significantly in response to hypoosmolality and returning
toward control values with correction of medium osmolality
(Table 3). Glutathione decreased from 4.33 0.98 nmol/mg
protein in isosmolar control cells to 2.01 0.13 nmol/mg protein
in hypoosmolar cells and subsequently increased to 4.38 0.65
30
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Table 3. Glutathione and taurine content in cultured brain cells
Mediurn Na concentration
100 mM
corrected to
140mM 100mM 140mM
C6 gliorna cells
Glutathione 6.33 1.94 4.26 1.04a 11.88 2•62b
Taurine 67.1 3.7 ND 32.5 2.1
N 6 5 5
SK-N-SH neuroblastoma cells
Glutathione 4.33 0.98 2.01 0.13a 4.38 0.65
Taurine 39.3 2.4 4.8 0.1' 34.1 0.9
N 6 7 7
Data are expressed as nmol/mg protein, n indicates the number of
replicate wells in each group. Abbreviation ND is none detected.
a P < 0.01 vs. 140 mM and corrected groups
< 0.01 vs. 140mM
nmol/mg protein in corrected cells. Respective values for taurine
were 39.3 2.4, 4.8 0.1, and 34.1 0.9 nmol/mg protein.
Cellular efflux of glutathione and taurine
Following exposure of both cell lines to either isosmolar or
hypoosmolar media, there was no difference in the media content
of glutathione (Table 4). As has previously been described for
glial cells [3], we identified significant efflux of taurine from C6
glioma cells in response to hypoosmolality.
Oxidative inJuiy in cultured brain cells
Release of 51Cr from hypoosmolar SK-N-SH cells exposed to
1.0 mM H202 was significantly greater than that in isosmolar cells
Table 4. Culture media content of glutathione and taurine following
60-minute exposure to hypoosmolar MEM
SK-N-SH
.MEM sodium
(mM)
C6 glioma neuroblastoma
140 100 140 100
GSH 3.31 0.40 3.57 0.26 1.72 0.25 1.96 .53
Taurine 9.8 2.0 36.0 1.1 19.4 3.5 20.8 2.4
Data are expressed as nmol/mg cell protein. N = 6 for each group.
a P < 0.001 vs. 140 mM
(35.4 1.7% vs. 19.0 2.4%; Fig. 2A; P < 0.001). H202-induced
cytolytic injury in hypoosmolar C6 glioma cells did not differ
significantly from injury in C6 cells grown in isosmolar media (Fig.
2B). 51Cr release from SK-N-SH cells in both isosmolar and
hypoosmolar media was significantly greater than the respective
51Cr release from C6 cells (P < 0.05, Fig. 2 A, B). In preliminary
studies, hypoosmolality alone did not increase 51Cr release above
isosmolar background levels from both SK-N-SH and C6 cells.
Discussion
Solute loss in response to extracellular hypoosmolality is a
beneficial adaptation in brain cells because it reduces brain edema
and avoids life-threatening increases in intracranial pressure.
However, there may be adverse consequences to osmotically-
induced depletion of metabolically important solutes. We present
in viva and in vitro data demonstrating depletion of the antioxi-
dants glutathione and taurine from rat brain and cultured brain
cells in response to hypoosmolality.
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Fig. 1. Correlation of total glutathione content in brain (A), heart (B), liver (C) and taurine content in brain (D), heart (E) and liver (F) with plasma sodium
in chronically hyponatremic, corrected hyponatremia, and normonatremic control rats. Data are pooled from all rats presented in Tables 1 and 2. N = 27
for brain and heart and 25 for liver.
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Fig. 2. A. Effect of hypoosmolaiity on H202-induced cytolytic injuly in
SK-N-SH cells. N = 12 for both experimental conditions. Hypoosmolar
SK-N-SH cells were incubated in media of progressively lower sodium
concentration over 48 hours with final sodium concentration of 100 mai
(R). Controls were maintained in isosmotic medium with sodium concen-
tration of 140 mai (1). ytolytic injury was quantitated with 51Cr release
after a 4-hour incubation with 1.0 mrvi I1zO2. 51Cr release in hypoosmolar
group is significantly greater than in isosmolar group (P < 0.001). 51Cr
release from SK-N-SH cells in both isosmotic and hypoosmotic conditions
is significantly greater than the respective values below for C6 glioma cells
(P < 0.05). B. Effect of hypoosmolality on cytolytic injury induced by 1.0
mM H202 in C6 glioma cells. N 6 for both groups. C6 glioma cells were
incubated in media of progressively lower sodium concentration over 48
hours with final sodium concentration of 100 msi (U. Controls were
maintained in isosmotic medium with sodium concentration of 140 mat
(s). ytolytic injury was quantitated with 51Cr release after a 4-hour
incubation with 1.0 mat H202. ns - no significant difference between 100
mM and 140 mM.
Brain total glutathione and taurine content decreased in re-
sponse to three days of hyponatremia and subsequently increased
following slow normalization of plasma sodium. Brain glutathione
correlated closely with plasma sodium across a wide range of
values. This osmotic sensitivity of glutathione was not found in
heart or liver, a finding which may reflect the more rigid volume
constraints placed on the brain compared to other tissues. We
further studied the adaptation to hypoosmolality in cell lines of
glial and neuronal origin. In C6 glioma and SK-N-SH neuroblas-
toma cells, contents of glutathione and taurine were significantly
reduced in response to a reduction in extracellular osmolality.
The specific cellular mechanisms responsible for these adaptive
changes in glutathione content are unknown. Glutathione is both
synthesized in brain from constituent amino acids [16, 24] and
transported directly across the blood-brain barrier as an intact
tripeptide [25]. In studies utilizing cultured astrocytes in isosmotic
media, Yudkoff and co-workers demonstrated release of intact
glutathione from these cells into the culture medium [21]. Me-
dium concentration of glutathione in these studies reached a
steady state by 60 minutes following the change of media. We
therefore examined glutathione efflux from C6 glioma and SK-
N-SH neuroblastoma cells following a 60-minute exposure to
hypoosmolar culture media. For both cell types, we found no
differences in the media content of glutathione in hypoosmolar
media when compared to isosmolar controls. This finding suggests
that osmotic depletion of brain cell glutathione is more likely due
to diminished synthesis. Given the rapid turnover of glutathione
in brain cells [21], a decrease in synthetic rate could quickly
translate into reduced cell content of glutathione. Significant
efflux of taurine from C6 cells into hypoosmolar media was
identified and is consistent with previous reports of osmotically-
induced taurine loss from astrocytes [3]. Osmotically-induced
release of taurine from cultured astrocytes occurs via pathways
sensitive to anion channel inhibitors [3]. Activation of these
pathways is the most likely explanation for these adaptive changes
in cell taurine content. Uptake of taurine by brain cells in
response to hyperosmolality appears to occur via a different
transport mechanism [26, 27].
The importance of glutathione as an antioxidant in brain is well
established. Depletion of glutathione to levels approximately
two-thirds of control values by buthionine sulfoximine makes rat
brain more susceptible to focal ischemic injury induced by middle
cerebral artery ligation [16]. This degree of glutathione depletion
approximates that found in the present studies of hyponatremia.
Similarly, global brain injury imposed by hyperbaric hyperoxia is
exacerbated by diethylmaleate-induced glutathione depletion
[15]. In addition to the role of glutathione in scavenging H2O2 and
organic peroxides, Yudkoff and co-workers raise the intriguing
possibility that glutathione synthesis by glial cells may serve as a
disposal pathway for glutamate, thereby minimizing the excito-
toxic potential of this amino acid [21]. Decreased synthetic rates
of glutathione induced by hypoosmolality may therefore foster
excitotoxic injury from accumulated glutamate.
Taurine, which is important to the normal maturation of the
central nervous system in cats and pre-term human infants [28,
29], may also be an important antioxidant in brain tissue. Taurine
is known to ameliorate oxidative injury in lung epithelial cells and
erythrocytes [6, 8], and to reduce injury in puromycin amino-
nucleoside nephrosis, a model of renal disease mediated by
reactive oxygen species [9]. Taurine reduces hypoxic injury in rat
hippocampal slices [13], but it is unclear if this finding is due to a
direct antioxidant effect of the amino acid or to taurine's modu-
lation of excitotoxic injury [10, 30]. The relatively low levels of
antioxidant enzymes such as catalase and superoxide dismutase in
brain increase the potential importance of the antioxidants gluta-
thione and taurine in this tissue [31, 32]. Moreover, agents which
facilitate injury caused by reactive oxygen species, such as iron and
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ascorbate, exist at high concentrations in brain [33, 34]. Even
under basal conditions, glutathione and taurine may serve an
important antioxidant role, since Sinet, Heikkila and Cohen have
demonstrated generation of H202 by normal rat brain in vivo [3I.
To investigate whether osmotic depletion of glutathione and
taurine from brain cells increases their susceptibility to oxidative
injury, we exposed cultured brain cells to H202. Once adapted to
hypoosmolar media, SK-N-SH cells were more susceptible to
cytolytic injury induced by H2O2 than were cells maintained in
isosmolar media. Miyamoto and co-workers demonstrated that
glutathione protects neuronal cells from oxidative injury imposed
by excitotoxic amino acids [36]. Interestingly, hypoosmolar C6
glioma cells were not more susceptible to H202 than were C6 cells
grown in isosmolar media. Enhanced vulnerability of SK-N-SH
cells compared to C6 cells was seen in isosmolar conditions and
became more significant under hypoosmolar culture conditions.
Osmotic depletion of glutathione and taurine may contribute to
this enhanced susceptibility of neuronal cells to oxidative injury.
The relative resistance of C6 cells to oxidative injury may be due
to the higher levels of glutathione in C6 cells in both isosmolar
and hypoosmolar media, thereby providing greater protection
from H202-induced injury. Higher levels of glutathione in glial
cells than in neuronal cells has previously been reported in
primary cultures of these cell types [37, 38]. In our in vivo studies,
the contribution of glutathione to the overall osmotic adaptation
of brain to hyponatremia is quite small (-0.5 mM). The impor-
tance of this reduction in brain glutathione content is related to
the loss of antioxidant capacity and not from glutathione's minor
contribution to volume regulation. Taurine is a quantitatively
more important solute in volume regulation with its concentration
in brain water falling approximately 3.5 m in response to
hyponatremia.
Chronic hyponatremia constitutes one of the most common
disturbances of fluid and electrolyte balance in clinical medicine
[39, 40]. In subarachnoid hemorrhage, a condition frequently
complicated by hyponatremia, Hasan, Wijdicks and Vermeulen
reported a significantly greater incidence of cerebral infarction in
those patients who developed hyponatremia when compared to
those who remained normonatremic [41]. Ischemic injury in this
setting could be related to depletion of brain antioxidants by
hyponatremia. Another complication of hyponatremia reported in
both animal models and humans is the development of demyeli-
nating brain lesions following the overly rapid correction of
chronic hyponatremia [1, 2, 42—44]. In a rat model, Mickel, Oliver
and Starke-Reed demonstrated increased oxidation of brain pro-
tein in rats subjected to rapid correction of hyponatremia [45].
This finding implicates a role for oxidative injury in the osmotic
demyelination syndrome. Osmotic depletion of antioxidants could
contribute to this phenomenon.
Considered together, our findings in vivo and in vitro identify
hypoosmolality-induced depletion of brain glutathione and con-
firm previous reports of the osmolyte function of taurine. While
contributing to the volume adaptation of brain during hyponatre-
mia, loss of these antioxidants may be maladaptive when viewed
from the perspective of defense against oxidative stress.
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